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Vitamin C (VC), widely used in food, pharmaceutical and cosmetic products, is susceptible to degradation, and
new formulations are necessary to maintain its stability. To address this challenge, VC encapsulation was achieved
via electrostatic interaction with glycidyltrimethylammonium chloride (GTMAC)-chitosan (GCh) followed by
cross-linking with phosphorylated-cellulose nanocrystals (PCNC) to form VC-GCh-PCNC nanocapsules. The par-
ticle size, surface charge, degradation, encapsulation efficiency, cumulative release, free-radical scavenging assay,
and antibacterial test were quantified. Additionally, a simulated human gastrointestinal environment was used to
assess the efficacy of the encapsulated VC under physiological conditions. Both VC loaded, GCh-PCNC, and GCh-
Sodium tripolyphosphate (TPP) nanocapsules were spherical with a diameter of 450  8 and 428  6 nm
respectively. VC-GCh-PCNC displayed a higher encapsulation efficiency of 90.3  0.42% and a sustained release
over 14 days. The release profiles were fitted to the first-order and Higuchi kinetic models with R2 values greater
than 0.95. VC-GCh-PCNC possessed broad-spectrum antibacterial activity with a minimum inhibition concen-
tration (MIC) of 8–16 μg/mL. These results highlight that modified CNC-based nano-formulations can preserve,
protect and control the release of active compounds with improved antioxidant and antibacterial properties for
food and nutraceutical applications.1. Introduction
Vitamin C (VC), commonly known as L-ascorbic acid, is a water-soluble
vitamin that helps construct the biological systems via various physio-
logical functions, such as hydroxylation reactions in collagen synthesis,
growth and repair of skin, and connective tissues (Bendich et al., 1986;
Naidu, 2003; Sauberlich, 1994). VC is an antioxidant necessary to prevent
damage to essential macromolecules in the body by scavenging harmful
free radicals caused by environmental pollution and possibly infectious
organisms (Bendich et al., 1986; Bodannes and Chan, 1979). Because of its
antioxidant potency, VC is quickly oxidized to dehydroascorbic acid (DHA)
and hydrolyzes at alkaline pH to form an irreversible 2,3-L-diketogulonate
(Simpson and Ortwerth, 2000). Therefore, encapsulating VC in nano-
particles can protect the degradation of the active compound from external
environments, including light, maintaining stability and enhances the
shelf-life of vitamin-based products.nocrystals; PCNC, Phosphorylate
NC; VC-GCh-TPP, Vitamin C-GTM
).
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servatives and the need for biodegradable and sustainable materials has
led to research into natural alternatives, notably chitosan biopolymers
and cellulose nanocrystals. Chitosan (Ch) is the second most abundant
natural polymer, making it ideal for biomedical and food applications
(Akhlaghi et al., 2015; Kumar, 2000). Because of its mucoadhesive
characteristics, the Ch delivery system can transport bioactive agents
with a longer residence time in the gastrointestinal tract with improved
bioavailability (Jimenez-Fernandez et al., 2014). In an acidic environ-
ment, Ch protonates and bind efficiently to anionic compounds (Rinaudo,
2006; Wang et al., 2017). However, Ch has low solubility above the pH of
6.5, which limits its application. Therefore, it is imperative to modify Ch
for extended applications over a wide pH range.
There are several reports on the synthesis of water-soluble Ch-com-
pounds (Lim and Hudson, 2003; Liu et al., 2011), and modifying Ch with
quaternary ammonium groups has been shown to significantly improved-CNC; TPP, Sodium tripolyphosphate; GCh, GTMAC-Chitosan; VC-GCh-PCNC,
AC-Chitosan with Sodium tripolyphosphate.
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Scheme 1. Schematic illustration describing the formation of VC-GCh-TPP and VC-GCh-PCNC nanocapsules by utilizing VC, GCh, TPP, and PCNC.
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to Ch by reacting with the epoxide rings yielding a cationic GCh that
could electrostatically bind to VC due to the presence of quaternary
ammonium groups. Furthermore, GTMAC has been shown to possess
better antimicrobial properties, which could preserve the nanocapsules
and VC from degradation (He et al., 2018). Henceforth, glycidyl trime-
thylammonium chloride (GTMAC) was conjugated to Ch to enhance the
solubility, attachment and preserve the negatively charged VC.
Cellulose nanocrystal (CNC) is extracted via sulfuric acid hydrolysis
to produce sulphated-CNC (SCNC). However, such a system may not be
suitable for biomedical or food applications since sulphated materials are
rarely used as food acidulants. On the other hand, phosphoric acid is
considered the most common inorganic food acidulant (Deshpande,
2002), and a safer and healthier hydrolyzing acid for functionalizing
CNC. Therefore, cellulose fibres were hydrolyzed using phosphoric acid
to isolate the crystalline regions of phosphorylated-cellulose nanocrystals
(PCNC) (Espinosa et al., 2013; Vanderfleet et al., 2018).
Sodium tripolyphosphate (TPP) is often used as a cross-linking agent to
prepare chitosan-TPP complexes. These complexes are metastable, as well
as having low mechanical strength, and therefore, they have limited ap-
plications as delivery systems (Alishahi et al., 2011; de Britto et al., 2012;
Katouzian and Jafari, 2016). To address this shortcoming, PCNC was
adopted as a novel cross-linking agent for GCh to produce VC encapsulated
nanocapsules (VC-GCh-PCNC) via ionic gelation. Wang et al. (2017) used
both TPP and SCNCs as cross-linking agents to encapsulate hydrophilic
anthocyanins. They confirmed that chitosan-SCNCs yielded more stable
capsules, where the external pH modulated the active molecule release
(Wang et al., 2017).
Desai and Park also showed that TPP cross-linked chitosan micro-
spheres displayed almost 100% cumulative VC release in approximately
6 h (Desai and Park, 2005). A better carrier system with a higher
encapsulation efficiency and sustained release rate, which also shields
the active ingredients (such as VC) from degradation (Ashrafizadeh et al.,
2020) is needed. Ideally, GCh-PCNC nanocapsules could provide a better
encapsulation, prolonged-release rate and enhanced stability than
existing carrier systems.
Based on this rationale, the present study seeks to produce a better
carrier system with a higher encapsulation efficiency and sustained
release of VC using GCh-PCNC nanocomplex. The VC nanocapsule
characteristics, such as particle size, degradation, encapsulation effi-
ciency, cumulative release, simulated release, and release kinetics, were
analyzed and elucidated. Additionally, we investigated the nanocapsule’s
antioxidant activity and antibacterial characteristics.2162. Materials and methods
2.1. Materials
Vitamin C (L-ascorbic acid), low to medium molecular weight chito-
san (Mw ¼ 50–190 kDa), phosphoric acid, glycidyl trimethylammonium
chloride, acetic acid, sodium acetate trihydrate, PBS buffer, hydrochloric
acid, and sodium hydroxide were purchased from Sigma-Aldrich (St.
Louis, MO, U.S.A.) and used as received.2.2. Preparation of VC-GCh-PCNC/VC-GCh-TPP nanocapsules
PCNC and GCh were prepared based on the previously reported
protocol with minor modifications (Baek et al., 2019). Initially, suspen-
sions of GCh (2 mg/mL) and PCNC (4 mg/mL) and a solution of TPP (0.9
mg/mL) were prepared in Milli-Q water. The concentrations of TPP and
PCNC were selected based on the phosphate ion concentrations. GCh and
PCNC suspensions were sonicated in a light-protected environment for
10 min (Misonix Sonicator XL-2000 Series, QSonica LLC) to produce a
stable dispersion. Under nitrogen purging, 0.5 mL of VC solution was
added to 10 mL of GCh, and the suspension was ultra-sonicated for 5 min.
A 2 mL of PCNC or TPP was added using a Harvard Apparatus syringe
pump into the VC-GCh dispersion every 50 s with continuous
ultra-sonication to obtain VC-GCh-PCNC/VC-GCh-TPP nanocapsules as
shown in Scheme 1. The prepared samples were stored in the dark at 4 C
and subsequently utilized for further evaluation.2.3. Characterization
2.3.1. FTIR
TPP and PCNC were analyzed using the FTIR spectrophotometer
(Bruker Tensor 27 FTIR spectrometer, Billerica, MA, USA) to confirm the
presence of phosphate groups. Freeze-dried samples were ground in a
mortar and compressed with potassium bromide (KBr) to form pellets.
FTIR spectra of each sample were recorded between 4000 cm-1 and 400
cm-1 with a resolution of 4 cm-1 and 32 scans.
2.3.2. Characterization of the nanocapsules
The particle size and zeta potential of VC-GCh, VC-GCh-PCNC and
VC-GCh-TPP were determined using a Malvern Zetasizer Nano ZS in-
strument (Nanosizer ZS, Malvern, UK). All the experiments were carried
out in triplicate.
Table 1
Experimental conditions to simulate the digestive system.
Digestive Region pH Time (h)
Upper Stomach 5 1
Lower Stomach 2 3
Duodenum 7.4 1
Small Intestine 5 3
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The morphology of SNPs was evaluated using a transmission electron
microscope (TEM, Philips CM10 electron microscope, an acceleration
voltage of 60 kV). The sample was placed on a 200-mesh carbon-coated
copper grid and air-dried before analysis.
2.4. Degradation analysis of VC
Degradation reaction upon storage or processing is the main problem
of nutritional quality loss. To determine the optimal conditions required
for further experimental studies, the degradation of VC at normal and
controlled conditions were conducted. VC solution, equivalent to the
concentration in the nanocapsules used in other studies, was prepared
using the phosphate-buffered saline (PBS, pH 7.4) in a rubber-stoppered
round bottom flask. Nitrogen purging and sample withdrawal were
facilitated through the inlet and outlet needles. The flask was covered
with aluminum foil and left to stir at 250 rpm at room temperature. For
comparison, another flask with the same experimental setup was used,
but without nitrogen purging and covering with the aluminum foil. At the
designated time intervals, 1 mL aliquot of the solution was withdrawn
and analyzed at 265 nm using a UV–Visible spectrophotometer (Cary 100
Bio UV–Vis spectrophotometer with quartz cuvettes). The concentration
of VC was determined from the calibration curve.
2.5. Determination of encapsulation efficiency
An encapsulation efficiency (EE, %) was performed on VC-GCh-PCNC
and VC-GCh-TPP nanocapsules. At first, 1 mL of the sample dispersion
was filtered using a 25 nm pore size membrane (Durapore membrane
filter PVDF 0.025 μm, Sigma-Aldrich, St. Louis, MO, U.S.A.) placed in a
stainless-steel syringe filter holder (Millipore and 1 Whatman 13 mm).
The VC content in the filtrate was measured using the Cary 100 Bio
UV–Vis spectrophotometer. The encapsulated VC concentration was
determined from the VC calibration curve and used to determine the EE
from Eq. (1) (Akhlaghi et al., 2015).
EEð%Þ¼ ½VCtotal  ½VCfiltrate½VCtotal
 100% (1)
where VCtotal is the absorbance of the control and VCfiltrate is the absor-
bance of the unbound VC.
2.6. Cumulative VC release study
The cumulative release of VC from VC-GCh-PCNC or VC-GCh-TPP was
performed based on the modified method of Desai and Park (2005). 10
mL of the nanocapsule dispersions was placed separately in a dialysis
bag, submerged in 25 mL of PBS (at pH 7.4 and 25 C) on a stirrer-plate
with continuous nitrogen purging and under controlled light exposure.
The dialysate was collected at predetermined time intervals (0–72 h, and
up to 14 days), and the VC release was analyzed using the Cary 100 Bio
UV–Vis spectrophotometer. A control test with a similar experimental
condition was also performed for the VC solution. This cumulative
release study was conducted in triplicate, and the average values were
reported.
2.7. DPPH free radical scavenging activity
A colorimetric 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay was used
to measure the free radical scavenging activity of VC, VC-GCh-PCNC and
VC-GCh-TPP. The method was adapted with a slight modification based
on the reported assay (Wang et al., 2017). DPPH is reduced when it reacts
with an antioxidant reagent, causing a colour change from violet to
yellow. Initially, the DPPH solution (0.025 mg/mL) was prepared in pure
methanol and protected from light using an aluminum foil. The nano-
capsule suspensions were filtered through a 25 nm pore size membrane,217and 0.15 mL of the filtrate was stirred with 1 mL DPPH solution in the
dark for 30 min and 5 days. Finally, the absorbance was measured using
the Cary 100 Bio UV–Vis spectrophotometer. The encapsulated VC con-
centration was determined from a standard VC calibration curve. The




where Acontrol is the absorbance of the control and Asample is the absor-
bance of the free VC.
2.8. Drug release kinetics and mathematical models
Various types of mathematical models have been used to determine
the kinetics of drug release from the delivery systems, such as zero order,
first order, and Higuchi model (Starychova et al., 2014; Zandi, 2017).
These dissolutionmodels are necessary to study the release mechanism of
drugs, as it mathematically describes the release profiles, such as the
release of VC.
The three models are shown below (Azevedo et al., 2014; Siepmann,
2013), where Mt is the amount of active ingredient eluted at time t, M0 is
the initial amount of VC in the solution (in most of the cases, M0 ¼ 0)
(Larsen et al., 2013; Rosenzweig et al., 2013).
Various kinetic release models
Zero-order equation: M0 - Mt ¼ K0t (3)
First-order equation: log M0 - logMt ¼ K1 t/2.303 (4)
Higuchi equation: M0- Mt ¼ KHt1/2 (5)
* K0 is the zero-order release constant.
* K1 is the first-order release constant.
* KH is the Higuchi dissolution constant.
2.9. Digestive system simulation release test
A released study was conducted in a simulated digestive system by
modifying the pH of the environment based on conditions shown in
Table 1 (Li et al., 2020). To mimic the gastrointestinal tract, the pH of the
system was altered by replacing the buffer solution at specified time in-
tervals using acetic acid-sodium acetate buffers for pH 2 and 5 and a PBS
buffer for pH 7.4. The release tests were performed in the dark with
continuous nitrogen purging and stirring with a magnetic stirrer at the
physiological temperature (37 C).
2.10. Antibacterial tests
Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus) were
used as the model for Gram-negative and Gram-positive bacteria
respectively. Each strain was streaked from 80 C glycerol stock on
Lauria-Bertani agar (LBA) plates and kept overnight at 37 C. Fully
grown, a single colony bacteria was inoculated in fresh LB medium in an
Erlenmeyer flask and incubated on a shaking incubator (250 r/min) for
16 h at 37 C. Phenotypic assays were performed using overnight cultures
after re-inoculating bacteria in LB broth at 0.05 initial turbidity at optical
density 600 nm. The effects of VC-GCh-PCNC on both bacteria were
evaluated using the standard broth dilution method. In brief, different
Fig. 1. (A) The IR spectra of TPP (upper trace) and P–CNC (lower trace); (B) Zeta potential and z-average particle sizes of VC-GCh, VC-GCh-PCNC and VC-GCh-TPP
nanocapsules, and (C) TEM images of (a): VC-GCh complex (Scale bar: 500 nm) (b): VC-GCh-TPP (Scale bar: 2 μm), and (c): VC-GCh-PCNC (Scale bar: 2 μm).
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mL) were dispersed in sterile LB broth and sonicated. Subsequently, the
turbidity of bacterial suspension (105 CFU/mL) was adjusted, co-
inoculated and incubated in a shaking incubator for 24 h. After that,
each of the bacteria-nanocapsule suspensions was serially diluted to
achieve 108 to 103 CFU/mL. The samples were vortexed for 5 s, and 100
μL of the suspension was spread on the agar plate and incubated for 24 h
at 37 C. Finally, the MIC was determined according to the lowest con-
centration that inhibited the maximum visible growth of microbes (Shi
et al., 2015).
2.11. Statistical analysis
All experiments were performed as three independent replicates, and
the results are expressed as the average with error bars of  standard
deviations.
3. Results and discussion
The loading of active ingredients, such as vitamins or drugs in the
nanoparticulate system can be prepared with surface charge interaction
mechanisms (de Britto et al., 2012). The active ingredients, either
physically entrapped (incubation) or adsorbed (incorporation) on the
surface of polymer matrices to form the particles (Radtchenko et al.,
2002). Polysaccharide nanoparticles (such as chitosan nanoparticle)
displayed enhanced loading efficiencies, and slow/sustained release
(Lazaridou et al., 2020). GCh is soluble in neutral pH medium, which
ensures that the chemical degradation of the vitamin does not occur
during the nanoparticle formation. The preparation, loading, and release
of VC in the GCh nanocapsules will be discussed later.
The FTIR was conducted to compare the two cross-linking agents and
confirm the functional groups on TPP and phosphoric acid hydrolysis for
preparing the PCNC. The spectra of both TPP, PCNC are shown in Fig. 1A.
The spectrum (enlarged view) of TPP possesses peaks at 1210-1218 cm-1
which are associated with the stretching vibration of P–O. The band at
1130-1156 cm-1 is assigned symmetrical and asymmetric stretching vi-
bration of PO2, and the peak at 1090-1094 cm-1 is attributed to the
symmetrical and asymmetric stretching vibration of PO3. The asym-
metric peak presents at 888-892 cm-1 is a result of P–O–P stretching
(Martins et al., 2012). To confirm the esterification of CNC through the218phosphoric acid hydrolysis, the IR spectrum of PCNC was also deter-
mined. As was similarly found in the IR spectrum of TPP, phosphate
groups were dominantly featured in the PCNC IR spectrum, revealing the
presence of P–OH stretching with peaks at 1000–1034 and 1223-1236
cm-1, a peak at 1164 cm-1 is attributed to P–O bands, and peak at be-
tween 464 and 452 cm-1 attributed to the HO–P–O band (Loutfy et al.,
2016).
In our previous study (Baek et al., 2019), we observed that the shape
of the nanocomplexes changed from a rod-like to hard-sphere and
random coil morphology as the GCh/PCNC ratios were increased. This
microstructure is considered to be optimal for the preparation of the VC
encapsulation system (Geng et al., 2015). The negatively charged PCNC
interacted with the positively charged GCh via electrostatic interaction at
all pHs, resulting in the retention of VC over a prolonged period. More-
over, CNC is a strong reinforcing agent for the polymer matrix (Geng
et al., 2015). Sampath et al. reported strong inter-and intramolecular
interactions, resulting from hydrogen bonding between hydroxyl and
amino groups on chitosan and hydroxyl groups on CNC (Sampath et al.,
2017). As a result, the complexation of PCNC and chitosan significantly
increased the mechanical properties of the nanocomplex. Poor mechan-
ical strength leads to low drug loading capacity and burst release of the
drug, whereas high mechanical strength produced a sustained drug
release due to strong interaction between drug and matrix (Xu et al.,
2020).
Lin et al. (2016) developed a double membrane hydrogel with anionic
alginate, and cationic CNC (CCNC) via electrostatic interactions and the
drugs were encapsulated within the membranes of the hydrogel. By
adding CCNC, enhanced mechanical properties, robust hydrogel and
sustained drug release were observed. This CCNC provided the “nano--
obstruction/locking effect” in the hydrogel, and it could be applied in the
drug delivery system for controlled drug release (Lin et al., 2016). TPP is
an ionic cross-linker, having three phosphate groups (triple-negative
charges), and it has been used as a cross-linking agent for chitosan. Since
chitosan has OH and NH2 groups, and the NH2 are easily protonated to
NHþ3 below its pKa, which could bind to the negative phosphate groups. It
has been reported that the conventional Ch-TPP complex is a metastable
system with poor mechanical and is highly pH-dependent. As the pKa of
chitosan is 6.5, thus at pH of 3.4, 5.5, and 6, 100%, 90% and 40% of
amino groups were protonated, respectively (Bayat et al., 2008; Karimi
et al., 2013). Additionally, Wei et al. (2020) reported that when the TPP
Scheme 2. Schematic illustrations describing the microstructure of the nanocapsules and the chemical functionality of each of the components.
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TH/Ch-TPP particles was observed within 2 h while at 0.04% of TPP
content, 90% of TH was slowly released within 5 h (Wei et al., 2020). In
comparison, our PCNC containing nanocapsules showed prolonged VC
release, hence they are considered to be a better delivery system.
Fig. 1B shows the size and zeta potential of the GCh nanocapsules
loaded with VC and cross-linked with TPP or PCNC. The larger particle
size of 620 nm was obtained by electrostatic interaction with negatively
charged VC and highly positive GCh. However, VC’s high affinity to-
wards GCh neutralized the cationic charges on the GCh, which reduced
the stability of the complex and might induce the aggregation of the
system (Fig.1Ca). This tendency of aggregation may be addressed using
other strategies to prepare a stable nanoparticulate system. The alter-
native methodologies of incorporating TPP or PCNC yielded highly stable
nanocapsules with zeta potential values of about 31 mV and 26 mV,
respectively. Eyley and Thielemans (2014) stated that the acid hydrolysis
of CNC using sulfuric or phosphoric acid imparted negative charges to the
CNC from the decoration of sulfate or phosphate groups on the surface of
CNC. If the phosphate groups on the CNC surface are insufficient, it has
the tendency to aggregate (Eyley and Thielemans, 2014). The alternative
methodologies of incorporating TPP or PCNC produced nanocapsules
with zeta potentials of about 30 mV, which is considered highly stable.
VC-GCh possessed a zeta potential (ZP) of ~þ9 mV, which decreased to
~ 30 mV when the VC-GCh was complexed with TPP and PCNC. The
average particle diameter of 450  8 and 428  6 nm was reported for
VC-GCh-PCNC and VC-GCh-TPP nanocapsules. Consequently, both
nanocapsules yielded 0.05 as the average PDI, confirming the uniform
size distribution of the nanocapsules without aggregation. Wang et al.
(2017) reported that anthocyanins, which are blueberry extracts, wereFig. 2. (A) Changes in concentration concerning the time of a 0.04 mg/mL VC sol
temperature. (B) The cumulative release profile of VC from nanocapsules through a
219added to form microcapsules with CNC and TPP as a cross-linking agent.
The anthocyanins were distributed in the entire microcapsule, such as on
the capsule surface, core, and matrix. In their prepared Ch-CNC micro-
capsules, anthocyanins were present in the core and the surface, whereas
anthocyanins were found on the surface of the Ch-TPP microcapsules.
The anthocyanins could not be encapsulated within the core due to the
weaker matrix with larger pores within the matrix. Besides, the sizes of
their Ch-CNC and Ch-TPP microcapsules were 265–969 nm and ~34 μm
respectively (Wang et al., 2017). However, the size of Ch-TPP subjected
to high-intensity ultrasonication was around 300 nm with a PDI of 0.53
(Tang et al., 2003). Fig. 1C depicts the morphology of VC-GCh (a),
VC-GCh-PCNC (b) and VC-GCh-TPP (c) nanocapsules, and Scheme 2
summarizes the microstructure of the nanocapsules and the chemical
functionality of each components, and the TEM images confirmed the
formation of spherical and monodispersed nanocapsules. The VC-GCh
mixture formed through ionic gelation possessed an amorphous struc-
ture of around 600–620 nm (Fig. 1Ca). Both VC-loaded VC-GCh-TPP
(Fig. 1Cb) and VC-GCh-PCNC nanocapsules (Fig. 1Cc) maintained a
spherical shape with an average size of 400–500 nm. The sample
cross-linked using PCNC showed enhanced contrast signals compared to
VC-GCh-TPP, associated with high VC encapsulation. Additionally, this
phenomenon supported our hypothesis of better cross-linking capacity
and higher VC loading in the GCh-PCNC system.
External environmental conditions, such as light, high temperatures,
low pH, and dissolved oxygen, could expedite the VC degradation
(Burdurlu et al., 2006; Zerdin et al., 2003). Therefore, it is essential to
protect the VC to yield the desired performance for a given application.
Removing dissolved oxygen in a light-protected environment is an
important measure to ensure no VC degradation. As shown in Fig. 2A,ution in PBS under nitrogen gas purging, limited light exposure, and constant
dialysis membrane to time.
Fig. 3. (A) DPPH absorption spectra, (B) DPPH free radical scavenging activity from the filtrates of nanocapsule dispersions of VC- GCh-TPP and VC-GCh-PCNC for 30
min, and (C) DPPH free radical scavenging activity from the filtrates of nanocapsule dispersions of VC- GCh-TPP and VC-GCh-PCNC for 5 days.
Table 2
Rate and correlation constants for both VC-GCh-PCNC and VC-GCh-TPP nano-
capsules fit zero-order, first-order, and Higuchi mathematical models.
Nanocapsule Zero-Order First-Order Higuchi
K0 (h-1) R2 K1 (h-1) R2 KH (h0.5) R2
VC-GCh-PCNC 0.05 0.92 3 10-4 0.97 0.77 0.96
VC-GCh-TPP 0.17 0.91 1.7 10-3 0.97 2.79 0.95
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compared to the VC exposed to ambient conditions. Without nitrogen
purging, degradation of VC occurred rapidly, where the VC degraded by
86%within the first 24 h and 100%within 4 days. Moreover, a controlled
environment prevented the degradation of VC, with the concentration
maintained at almost 98% at the end of 5 days. Thus, the optimal con-
dition for conducting the VC release required continuous nitrogen
purging, which was being adopted for the accurate VC quantification
from the prepared nanocapsules.
The encapsulation efficiency for both VC-GCh-PCNC and VC-GCh-TPP
nanocapsules were measured in neutral pH. Since the pKa of vitamin C is
pH 4.2 and 11.6 (Tian et al., 2009), the vitamin C was partially ionized at
neutral pH, yielding negative charges that would bind to GCh, resulting
in a higher encapsulation of VC. The indirect method yielded an EE of
90.3  0.42% for VC-GCh-PCNC, which was 33% higher than
VC-GCh-TPP (57.3  0.28%) nanocapsules. This significant difference in
EE confirmed that nanocapsules prepared using GCh and PCNC possessed
good encapsulation of VC and stability due to the chemical bonding
compared to the weaker TPP cross-linked VC-GCh-TPP nanocapsule
system. In the previous study by Desai and co-workers, the encapsulation
efficiency of VC loaded Ch-TPP capsules using different molecular weight
types were between 52.74 and 67.25% (Desai et al., 2006).
An incremental release test to simulate food storage performed over
14 days under continuous nitrogen purging conditions is shown in
Fig. 2B. A burst release of more than 75% in the first few hours was
observed for VC only (control) compared to 40% for VC-GCh-TPP and
10% for VC-GCh-PCNC, thereby confirming the importance of encapsu-
lation. We observed that the VC-GCh-TPP nanocapsules displayed a more
rapid release profile of 42% within a day and approached 76% within
two weeks. In contrast, VC-GCh-PCNC showed a slow-release of VC,
approaching about 18% over the extended period of 14 days. A slow
release of VC was achieved using VC-GCh-PCNC, since the PCNC
possessed a more robust and a durable cross-links with GCh compared to
TPP. Water-soluble GCh crosslinked using TPP has been reported for
encapsulating protein, insulin, quercetin, and Bovine Serum Albumin
(BSA) (Rwei et al., 2014; Zhang et al., 2010), and an initial burst coupled
with a slow/continuous release were observed in an in-vitro study.
Despite the high EE% and slow release rate of GCh-TPP compared to
Ch-TPP, almost 72–80% were released within 24 h due to the weak
ionization degree of GCh at pH 7.4 and fewer positively charged groups.
However, in our study, PCNC functioned as a filler for the GChmatrix (Xu
et al., 2019), thereby improving the mechanical strength of the nano-
capsules that contributed to the controlled release of VC. Therefore, the
VC-GCh-PCNC would be more useful for the long-term storage of active
ingredients in foods, cosmetics, and personal care applications.
The DPPH solution is violet in color and has a characteristic UV–vi-
sible absorption peak at 517 nm in the non-reduced state (Fig. 3A). The
results of the DPPH free radical scavenging activity experiments for VC,
VC-GCh-TPP, and VC-GCh-PCNC nanocapsules for 30 min are shown in
Fig. 3B. A higher scavenging activity in the filtrate (free VC) corre-
sponded to a lower encapsulating capacity of the nanocapsules and vice220versa. As seen in Fig. 3B, the filtrate of VC-GCh-PCNC possessed a low
scavenging activity of 13.5  0.58% compared to VC-GCh-TPP (44.7 
0.89%) and free VC (56.7  0.62%) after 30 min. Fig. 3C shows the
antioxidant power over 5 days, displaying still lower scavenging activity
(%) for the VC-GCh-PCNC. However, in contrast, the retained VC in GCh-
PCNC nanocapsules possessed a significant free-radical scavenging ac-
tivity than VC in GCh-TPP. Since PCNC provided a better cross-linking
capacity with GCh yielding a compact nanocapsule that preserved the
VC from external degradation over a long storage time.
The data obtained from the VC release studies from VC-GCh-PCNC
and VC-GCh-TPP nanocapsules were used to elucidate the various drug
release kinetic models (Zero-Order, First-Order, and Higuchi). The zero-
order release corresponds to a constant release with the same amount of
VC release per unit time. The first-order model is a concentration-
dependent release with the same rate of drug release per unit time, and
corresponded to a sustained-release and matrix diffusion-controlled
release. The Higuchi model can be used to determine the release of the
drug from the matrix (Fu and Kao, 2010; Mircioiu et al., 2019). Based on
equations (3-5), the best kinetic model was determined by the highest
coefficients of determination (R2). These kinetic equations offer insights
into the VC release mechanism, and delivery behaviour from nano-
capsules. Besides, the rate constants (k) were obtained from the linear
regressions of these models (Table 2), and they were used to identify the
best model for the release of VC from the nanocapsules. Both first-order
and Higuchi models yielded sufficiently high correlation constants
(>0.95), indicating a good fit for the kinetic data. A first-order fit sug-
gests that the release of VC from the nanocapsules corresponded to the
sustained-release and matrix diffusion-controlled release. In contrast, a
good fit to the Higuchi model represented a diffusing water-soluble drug
in a matrix system, where the square root of time-dependent release is
associated with the Fickian diffusion (Caccavo et al., 2015; Chiarappa
et al., 2017). In summary, the VC release was mediated by diffusion from
the GCh matrix, where the VC was electrostatically bound. The diffusion
rate was attributed to the GCh-PCNC polymer matrix’s strength due to
cross-linking resulting in the lowest VC release. It was evident from
Table 2 that the kinetic constants of VC-GCh-PCNC were 3–4 times lower
than VC-GCh-TPP, which further confirmed that PCNC was a better
cross-linking agent.
* K0 is the zero-order release constant.
* K1 is the first-order release constant.
Fig. 4. (A): diagram of human digestive system and (B): In vitro simulation of various conditions of the digestive system of VC-GCh-PCNC.
J. Baek et al. Current Research in Food Science 4 (2021) 215–223* KH is the Higuchi dissolution constant.
Theoretically, as depicted in Fig. 4A, orally swallowed food passes
through the esophagus to reach the stomach in several seconds. The food
remains in the stomach and is digested by the gastric acid and enzymes
(pH 1–3, 1.5–4 h), after which it enters the duodenum, and the small
intestine via peristalsis, induced by a series of muscular contractions. It is
mixed with digestive juices and enzymes from the pancreas, liver, and
intestine (pH 6–8, 1–2 h), where the water and nutrients are absorbed
into the bloodstream. As peristalsis continues, the food and fluid move-
ment’s conveyed the undigested fractions to the large intestine (pH 5–7,
12–24 h) where the remaining water is absorbed, resulting in the solid
stool (McClements and Li, 2010). The digestion of VC occurs similarly,
and after ingestion, it will be oxidized to DHA and absorbed in the small
intestine (Aky€on, 2002). The release profiles of VC-GCh-PCNC in a
simulated human digestive system at the specific pH environments and
pH 7.4 (control) are shown in Fig. 4B. When changing the release me-
dium pH to simulate the conditions of the digestive system, it was
observed that a higher cumulative VC release over 8 h was observed
compared to the release at the control pH of 7.4. At 8 h, the digestion
simulation had achieved a release of approximately 27%, compared to
neutral pH, where less than 10% of the VC was released. Since chitosan
and CNC possess mucoadhesive property, they could attach to the mu-
cous membrane and slowly release the VC. Cationic chitosan exhibited
high mucoadhesive properties and could bind to negatively charged
mucin, resulting in a strong mucosal adhesion. Moreover, the high sur-
face area could interact with mucin rather than Tempo-CNF and CNF,
and hydrophobic attraction or hydrogen bonding promotes the adhesion
of mucin to CNC (Lin et al., 2019). After digestion, chitosan could be
degraded by enzymes, such as lysozyme and human bacterial enzymes in
our body fluid especially in our lungs and colons. Loncarevic et al. stated
that in the enzymatic digestion process, the enzyme first diffuses to theFig. 5. Antimicrobial activity of VC- GCh-PCNC with E. coli and with S. aureus. (*M
not shown).
221solution and partitions to the surface of the complex. The enzyme on the
complex initiates the catalytic reaction that results in the scission of the
macromolecular backbone, and the bioactive substance is then released
into the bulk solution (Loncarevic et al., 2017). If the chitosan complex is
porous, then the degradation would occur more rapidly. Hence with the
addition of CNC, which acted as a reinforcement in the chitosan complex,
the degradation and burst releasing were significantly reduced. However,
as there is a lack of cellulase intake by the human body, most of the CNC
will be excreted, or it could be fermented by gut microflora, such as
Ruminococcus champanellensis present in the human fecal (Zhang et al.,
2018). The pH sensitivity of the nanocapsules is desirable in food prep-
arations to ensure that VC remains encapsulated and protected during
storage, whereby in the digestive tract following ingestion, a controlled
release is desirable.
It is well-known that chitosan possesses antibacterial properties
against a wide range of microorganisms. The antimicrobial characteristic
of chitosan is affected by intrinsic and extrinsic factors, such as strain, pH,
ionic strength, molecular weight or degree of deacetylation of chitosan
etc. Chitosan loses its antimicrobial function above its pKa due to the
deprotonation of the amino groups and its low solubility in water.
However, Atay (2019) claimed that chitosan has limited activity because
amino groups in chitosan backbone can only act as weak positive charge
center (Atay, 2019). Therefore, in this study, we enhanced the antibac-
terial property by grafting GTMAC to the chitosan backbone to introduce
more cationic groups to the chitosan that will bind to the negative cell
membrane and kill the bacteria. The range of antimicrobial activities of
GCh against E. coli and S. aureus was 16–32 μg/mL and 8–16 μg/mL,
respectively (Fig. 5). Other reasons for the antimicrobial effects of the
complex are: VC has been shown to possess antibacterial property against
S. epidermidis, E. coli and P. aeruginosa (Pandit et al., 2017) and low
concentration of VC (0.15 mg/mL) inhibited the growth of S. aureus
(Mousavi et al., 2019). Liping et al. (2020) developed water-solubleIC values of GTMAC-Chitosan for two types of bacteria were 32–64 μg/mL-data
J. Baek et al. Current Research in Food Science 4 (2021) 215–223chitosan with vitamin C complex (CSVC) and confirmed its antibacterial
activity against E. coli. Compared to the blank control, the MIC of CSVC
against E. coliwas about 5 mg/mL (Liping et al., 2020). In this study, due
to the quaternary ammonium groups and the presence of VC, the nano-
capsule system inhibited the pathogenic bacteria population at minimal
concentrations. Thus, VC-GCh-PCNC could reduce bacteria contamina-
tion over a reasonably long period, making them a suitable antimicrobial
agent for functional food systems.
4. Conclusions
This study examines the stabilization mechanism and effectiveness of
PCNC over TPP on improving the stability, encapsulation, and VC release
in the VC-GCh-PCNC nanocapsule system. PCNC could effectively stabi-
lize the system via stronger ionic gelation compared to TPP. The stability
of VC in the system is highly dependent on light, pH, and dissolved ox-
ygen of the environment. A better kinetic release of VC was achieved
under nitrogen purge. The PCNC cross-linked nanocapsules possessed a
sustained release profile, making them ideal candidates for prolonged VC
storage. The kinetic release profiles were fitted to the first-order and
Higuchi kinetic models (R2 > 0.95), showing a concentration-dependent
release from the VC-GCh-PCNC nanocapsule system. A digestive system
simulated in vitro release tests by varying the pHs, which showed a faster
release rate at low pHs that was attributed to the degree of quaternization
of GCh. The sedimented VC-GCh-PCNC possessed a higher antioxidant
capacity than VC-GCh-TPP. Additionally, the MIC for E. coli and S. aureus
bacterial strains were between 8 and 16 μg/mL, which suggested that the
VC-GCh-PCNC nanocapsules were efficient antimicrobial agents that
could extend the shelf-life of food systems . These results showed that the
VC’s stability was enhanced in the presence of PCNC, thereby offering a
strategy for the preservation of highly unstable compounds (such as VC)
during long-term storage in functional food systems.
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